Literature DB >> 25062635

Immunodeficient mouse model for human hematopoietic stem cell engraftment and immune system development.

Ken-Edwin Aryee1, Leonard D Shultz, Michael A Brehm.   

Abstract

Immunodeficient mice engrafted with human immune systems provide an exciting model to study human immunobiology in an in vivo setting without placing patients at risk. The essential parameter for creation of these "humanized models" is engraftment of human hematopoietic stem cells (HSC) that will allow for optimal development of human immune systems. However, there are a number of strategies to generate humanized mice and specific protocols can vary significantly among different laboratories. Here we describe a protocol for the co-implantation of human HSC with autologous fetal liver and thymic tissues into immunodeficient mice to create a humanized model with optimal human T cell development. This model, often referred to as the Thy/Liv or BLT (bone marrow, liver, thymus) mouse, develops a functional human immune system, including HLA-restricted human T cells, B cells, and innate immune cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25062635      PMCID: PMC4476265          DOI: 10.1007/978-1-4939-1133-2_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  24 in total

Review 1.  Humanized mice in translational biomedical research.

Authors:  Leonard D Shultz; Fumihiko Ishikawa; Dale L Greiner
Journal:  Nat Rev Immunol       Date:  2007-02       Impact factor: 53.106

2.  Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1.

Authors:  Michael W Melkus; Jacob D Estes; Angela Padgett-Thomas; Joel Gatlin; Paul W Denton; Florence A Othieno; Anja K Wege; Ashley T Haase; J Victor Garcia
Journal:  Nat Med       Date:  2006-10-22       Impact factor: 53.440

3.  Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation.

Authors:  Ping Lan; Noriko Tonomura; Akira Shimizu; Shumei Wang; Yong-Guang Yang
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

Review 4.  The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID.

Authors:  K Sugamura; H Asao; M Kondo; N Tanaka; N Ishii; K Ohbo; M Nakamura; T Takeshita
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

5.  Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.

Authors:  Leonard D Shultz; Bonnie L Lyons; Lisa M Burzenski; Bruce Gott; Xiaohua Chen; Stanley Chaleff; Malak Kotb; Stephen D Gillies; Marie King; Julie Mangada; Dale L Greiner; Rupert Handgretinger
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

Review 6.  Of mice and not men: differences between mouse and human immunology.

Authors:  Javier Mestas; Christopher C W Hughes
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

7.  Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.

Authors:  X Cao; E W Shores; J Hu-Li; M R Anver; B L Kelsall; S M Russell; J Drago; M Noguchi; A Grinberg; E T Bloom
Journal:  Immunity       Date:  1995-03       Impact factor: 31.745

8.  Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells.

Authors:  L Covassin; S Jangalwe; N Jouvet; J Laning; L Burzenski; L D Shultz; M A Brehm
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

9.  Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice.

Authors:  Diana M Brainard; Edward Seung; Nicole Frahm; Annaiah Cariappa; Charles C Bailey; William K Hart; Hae-Sook Shin; Sarah F Brooks; Heather L Knight; Quentin Eichbaum; Yong-Guang Yang; Megan Sykes; Bruce D Walker; Gordon J Freeman; Shiv Pillai; Susan V Westmoreland; Christian Brander; Andrew D Luster; Andrew M Tager
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

10.  A prescription for human immunology.

Authors:  Mark M Davis
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

View more
  19 in total

Review 1.  Understanding Disease Biology and Informing the Management of Pancreas Cancer With Preclinical Model Systems.

Authors:  Martin C Whittle; Sunil R Hingorani
Journal:  Cancer J       Date:  2017 Nov/Dec       Impact factor: 3.360

2.  Role of Interferon-γ-Producing Th1 Cells in a Murine Model of Type I Interferon-Independent Autoinflammation Resulting From DNase II Deficiency.

Authors:  Sudesh Pawaria; Kerstin Nündel; Kevin M Gao; Stephanie Moses; Patricia Busto; Kevin Holt; Rohit B Sharma; Michael A Brehm; Ellen M Gravallese; Merav Socolovsky; Anette Christ; Ann Marshak-Rothstein
Journal:  Arthritis Rheumatol       Date:  2019-12-29       Impact factor: 10.995

3.  Gene Therapy with an Adeno-Associated Viral Vector Expressing Human Interleukin-2 Alters Immune System Homeostasis in Humanized Mice.

Authors:  Philip A Durost; Ken-Edwin Aryee; Fatima Manzoor; Roland M Tisch; Christian Mueller; Agata Jurczyk; Leonard D Shultz; Michael A Brehm
Journal:  Hum Gene Ther       Date:  2017-10-03       Impact factor: 5.695

Review 4.  Human T-cell leukemia virus-associated malignancy.

Authors:  Amanda R Panfil; Michael P Martinez; Lee Ratner; Patrick L Green
Journal:  Curr Opin Virol       Date:  2016-08-31       Impact factor: 7.090

5.  Development of a huBLT Mouse Model to Study HCMV Latency, Reactivation, and Immune Response.

Authors:  Lindsey B Crawford; Patrizia Caposio
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Modeling hepatitis B virus infection, immunopathology and therapy in mice.

Authors:  Liang Cheng; Feng Li; Moses T Bility; Christopher M Murphy; Lishan Su
Journal:  Antiviral Res       Date:  2015-06-19       Impact factor: 5.970

7.  Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia.

Authors:  Daniel T Claiborne; Timothy E Dudek; Colby R Maldini; Karen A Power; Musie Ghebremichael; Edward Seung; Elizabeth F Mellors; Vladimir D Vrbanac; Katharine Krupp; Abigail Bisesi; Andrew M Tager; David M Knipe; Christian L Boutwell; Todd M Allen
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

Review 8.  The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents.

Authors:  Y Maurice Morillon; Ariana Sabzevari; Jeffrey Schlom; John W Greiner
Journal:  Anticancer Res       Date:  2020-10       Impact factor: 2.480

9.  Human Anti-HIV-1 gp120 Monoclonal Antibodies with Neutralizing Activity Cloned from Humanized Mice Infected with HIV-1.

Authors:  Melissa A Gawron; Mark Duval; Claudia Carbone; Smita Jaiswal; Aaron Wallace; Joseph C Martin; Ann Dauphin; Michael A Brehm; Dale L Greiner; Leonard D Shultz; Jeremy Luban; Lisa A Cavacini
Journal:  J Immunol       Date:  2018-12-28       Impact factor: 5.422

10.  The HIV-Tat protein interacts with Sp3 transcription factor and inhibits its binding to a distal site of the sod2 promoter in human pulmonary artery endothelial cells.

Authors:  Terrin L Manes; Ari Simenauer; Jason L Geohring; Juliana Flemming; Michael Brehm; Adela Cota-Gomez
Journal:  Free Radic Biol Med       Date:  2019-12-19       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.